NSE filing, NSE: TRENT. Summary written from the filing by ALFA Finder's alert engine.
Trent Ltd: key numbers
- Share price
- ₹2,913.90
- Market cap
- ₹1,55,379 Cr
- Revenue (annual)
- ₹20,074 Cr
- Net profit (annual)
- ₹1,720 Cr
- P/E (TTM)
- 85.9×Sector 61.5×
- Promoter holding
- 37.01%+0.00% QoQ
- FII holding
- 15.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Trent Ltd
All →Trent Merger & Restructuring Worth ₹171.9 Cr
Trent agreed on 22 October 2026 to sell a unit or subsidiary to TreBits Investment Trust, an unrelated buyer. Completion is expected by 31 December 2026.
- Value
- ₹171.9 Cr
Trent Merger & Restructuring
Trent's subsidiary Nahar signed a binding term sheet to divest 100% of Netria Property Holdings to TreBits REIT. Consideration is Rs 11.25 per share plus about Rs 171.91 crore of loan repayment, subject to conditions.
Trent Management Change
Mr. Harish Bhat, a Non-Executive Non-Independent Director of Trent Ltd., has resigned from the Board of Directors effective 17th October 2026, citing personal and professional commitments.
Trent Other Announcement
Trent Ltd has submitted its shareholding pattern for the quarter ended September 30, 2026. This filing is a routine regulatory compliance requirement.
Trent Board Meeting Date
Trent Ltd has scheduled its Board Meeting for 29 October 2026 to approve Q2 and half-year results. The trading window is closed from 24 September to 31 October 2026.
Trent Results Update
Trent Limited provided a Q2 and H1 FY27 operational update, reporting standalone revenue and a total store count of 1,342 across its various lifestyle brands.
- total store portfolio
- 1342.0 stores
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.